Company Filing History:
Years Active: 1993
Title: Innovations in Biotechnology: The Contributions of Nancy Webb
Introduction
Nancy Webb is a notable inventor based in College Station, TX, known for her significant contributions to the field of biotechnology. With her expertise and dedication in research, she has developed a patented technology that advances our understanding of transforming growth factor beta-2 (TGF-.beta.2).
Latest Patents
Nancy Webb holds a patent for the "Cloning and Expression of Transforming Growth Factor Beta-2." This patent details the cDNA clones that code for TGF-.beta.2, which are instrumental in constructing expression vectors capable of directing the high-level production of biologically active mature TGF-.beta.2 and its precursor forms. The invention particularly highlights techniques for expressing TGF-.beta.2 in transfected Chinese Hamster Ovary (CHO) cells and COS cells. The patent showcases CHO cells transfected with the plasmid vector that carries the complete 414 amino acid simian TGF-.beta.2 precursor, achieving an impressive secretion level of approximately 5 µg per ml of culture media.
Career Highlights
Nancy Webb has made remarkable strides in the biotechnology sector, working at Oncogen, where her research and innovations play a crucial role in developing therapeutic solutions. Her pioneering approach not only enhances the scientific community's understanding of TGF-.beta.2 but also holds potential applications in related medical fields.
Collaborations
During her career, Nancy has collaborated with prominent colleagues, including Anthony F. Purchio and Linda Madisen. These partnerships have fostered a productive research environment that has led to significant advancements in their respective fields and have further driven innovation within Oncogen.
Conclusion
Nancy Webb's work exemplifies the impact of innovative thinking and research in biotechnology. Her patent on TGF-.beta.2 represents a significant milestone that not only advances our comprehension of growth factors but also underlines the importance of collaborative efforts in science and technology. As she continues her journey at Oncogen, her contributions promise to pave the way for future breakthroughs in the industry.